Trial ID or NCT#

NCT01716117

Status

not recruiting iconNOT RECRUITING

Purpose

This clinical research study is designed to determine safety and effectiveness of the Surpass Flow Diverter (Surpass System), an investigational device developed to treat wide-neck, large or giant intracranial aneurysms. An intracranial aneurysm is a bulge in the wall of a blood vessel in the brain. The bulge is caused by a weakening of the vessel wall. If left untreated, the bulge may continue to grow larger and ultimately the vessel may break open (rupture), resulting in serious bleeding into or around the brain. The information collected from this study will be used to evaluate how well patients do when treated with the Surpass System both immediately after treatment of an aneurysm and over a long period of time (5 years).

Official Title

The Surpass Intracranial Aneurysm Embolization System Pivotal Trial to Treat Large or Giant Wide Neck Aneurysms (SCENT Trial)

Eligibility Criteria

Ages Eligible for Study: 19 Years to 80 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Robert Dodd, MD, PhD
Robert Dodd, MD, PhD
Cerebrovascular neurosurgeon, Pituitary tumors neurosurgeon, Neurosurgeon, Neurosurgeon, Interventional neuroradiologist
Associate Professor of Neurosurgery, of Radiology and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS)
Huy M. Do, MD
Huy M. Do, MD
Interventional neuroradiologist, Radiologist
Professor of Radiology (Neuroimaging and Neurointervention) and, by courtesy, of Neurosurgery and of Otolaryngology - Head & Neck Surgery (OHNS)

Contact us to find out if this trial is right for you.

CONTACT

Kara Richardson
(650) 736-6171